Relationship between lipophilicity and toxicity of essential oils

Author: Pauli, A.

Source: International Journal of Essential Oil Therapeutics, Volume 2, Number 2, July 2008 , pp. 60-68(9)

Publisher: Essential Oil Resource Consultants

Buy & download fulltext article:

OR

Price: $35.00 plus tax (Refund Policy)

Abstract:

The lipophilicity of 25 essential oils was determined through calculation of the lipophilicity (log P) of individual essential constituents and the percentage composition of the essential oils, respectively. The lipophilicity of the essential oils (log Pmix) increased in the order: cassia, cinnamon, mustard, parsley, eucalyptus, clove, peppermint, sage, rosemary, anise, lemongrass, fennel, citronella, caraway, thyme, lavender, pine needle, bergamot, dwarf-pine, turpentine, angelica, lemon, rose, sweet flag and chamomile. The log Pmix values correlated significantly (r2 = 0.82) with the acute oral toxicity of 18 essential oils towards rats, whereby toxicity decreases with increasing lipophilicity. The opposite is known for several classes of organic compounds, where toxicity towards living organisms increases with increasing lipophilicity. Therefore, lipophilic essential oils such as chamomile and/or lipophilic sesquiterpenes like (-)-α-bisabolol, farnesol and nerolidol or diterpenes such as sclareol present interesting, pharmacologically active, nontoxic substances worthwhile for further investigation.

Keywords: ESSENTIAL OIL; LIPOPHILICITY; TOXICITY; SESQUITERPENES

Document Type: Research article

Publication date: 2008-07-01

More about this publication?
  • The International Journal of Essential Oil Therapeutics is destined for individuals and establishments that have an interest in the bioactivity of aromatic plants, as well as the potential applications of such activities in human and animal treatment modalities. The Journal publishes a range of pertinent subject matter including in vitro and in vivo research, clinical trials, pilot studies, adverse reaction and drug interaction reports and scientifically based discussion relating to therapeutic applications.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Information for Advertisers
  • ingentaconnect is not responsible for the content or availability of external websites
Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page